Mootral
Mootral is a technology company.
Financial History
Mootral has raised $9.0M across 2 funding rounds.
Frequently Asked Questions
How much funding has Mootral raised?
Mootral has raised $9.0M in total across 2 funding rounds.
Mootral is a technology company.
Mootral has raised $9.0M across 2 funding rounds.
Mootral has raised $9.0M in total across 2 funding rounds.
Mootral has raised $9.0M in total across 2 funding rounds.
Mootral's investors include 01 Advisors, Afore Capital, Alumni Ventures, Backend Capital, Basecamp Fund, Flucas Ventures, Gradient Ventures, Infinite Niches, KittyHawk Ventures, Moxxie Ventures, Prototype Capital, Ravelin Capital.
Mootral is a British-Swiss AgriTech company founded in 2018 that develops natural feed supplements for livestock to reduce greenhouse gas emissions, particularly methane from ruminants like cattle, while improving animal health and farmer economics[1][2][5][8]. Its flagship product, Mootral Ruminant (now Enterix), cuts methane emissions by up to 38% using garlic and citrus-derived compounds, generates carbon credits via the Verified Carbon Standard (VCS), and boosts milk yields and ROI for dairy and beef farmers[1][2][3][5]. A second product targets antibiotic reduction in pigs and poultry by enhancing gut health, with trials underway in Latin America and Europe; the company has raised $35.63M and holds 6 patents[1][2]. Mootral serves farmers, protein producers, and governments, addressing climate change and antimicrobial resistance in animal agriculture with scalable, natural solutions[1][2][4][7].
Mootral emerged in 2018 as a spin-out from a British biotech company, founded by CEO Thomas Hafner in Switzerland before basing operations in London, England[1][2][5]. The idea stemmed from research into ruminant microbiomes, focusing on inhibiting methane-producing archaea through natural inhibitors like garlic compounds and bioflavonoids, inspired by the urgent need to curb agriculture's 14.5% share of global GHG emissions[5][8]. Early traction came from lab-proven near-complete methane inhibition, followed by in vivo refinements to balance efficacy, animal welfare, and productivity; the company quickly partnered for VCS carbon credits and commercial farm trials in the UK[1][5]. Pivotal moments include patent filings under WIPO's PCT for international protection and recent advancements like Enterix Advanced, doubling efficacy with iodoform for grazing cattle[3][6].
Mootral rides the agricultural decarbonization wave, targeting livestock methane (one-third of human-caused emissions) amid global net-zero pledges and regulations like the EU's methane strategy and US farm bill incentives[1][5][6]. Timing aligns with surging demand for verifiable carbon credits and sustainable protein, fueled by consumer pressure and policies valuing nature-based solutions over unproven tech[1][8]. Market forces favor it: North America's 30-40% share in methane mitigation with 7-9% CAGR, plus scalability to 300 million cows in a decade via affordable, approved compounds like non-carcinogenic iodoform[2][3][6]. It influences the ecosystem by proving "good business in doing good," partnering with majors like Cargill, validating natural additives, and bridging farmers, policymakers, and investors for planetary-scale adoption[1][3][5].
Mootral is poised to dominate livestock emissions reduction, with 2024 in vivo trials for Enterix Advanced targeting 40-60% efficacy and regulatory nods by late 2026, enabling bolus rollout to grazing herds worldwide[3][6]. Scaling to 300 million cows via trials in New Zealand, Europe, Latin America, and the US will leverage rising carbon markets and antibiotic bans, while a second monogastric product expands addressable market[1][6]. Trends like AI-optimized microbiomes and blended finance will amplify growth, evolving Mootral from niche innovator to AgriTech leader—proving climate-smart cows secure sustainable food systems, just as its founders envisioned[1][8].
Mootral has raised $9.0M across 2 funding rounds. Most recently, it raised $3.0M Seed in August 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2020 | $3.0M Seed | 01 Advisors, Afore Capital, Alumni Ventures, Backend Capital, Basecamp Fund, Flucas Ventures, Gradient Ventures, Infinite Niches, KittyHawk Ventures, Moxxie Ventures, Prototype Capital, Ravelin Capital, Science, Scribble Ventures, Shrug Capital, SignalFire, Sound Ventures, Spacecadet Ventures, SV Angel, Tusk Venture Partners, Weekend Fund, Alper Kiresepi, Anna Patterson, Howard Charney, Kevin Weil, Moshe Lifschitz, Peter Hunn, Rudra Peram, Tom McInerney, Tyler Willis, Yagiz Sozmen, Zach Segal, Andrew Wheeler, Flybridge Capital Partners, Grit Ventures, Momenta Ventures, Toyota Ventures, Village Global | |
| Nov 1, 2019 | $6.0M Seed | 01 Advisors, 2xN, Broom Ventures, Catapult Capital, Moonshots Capital, Pelion Venture Partners, Science, Thomas Pentz, TQ Ventures, What If Ventures, Charlie Songhurst, Clark Landry, John Spindler |